Cite

HARVARD Citation

    Shaw, B. et al. (2018). PROMIS measures can be used to assess symptoms and function in long‐term hematopoietic cell transplantation survivors. Cancer. 124 (4), pp. 841-849. [Online]. 
  
Back to record